These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 590080)

  • 1. [Electron microscopic study of the molecular forms of products of unstabilized fibrin dissolution by complex compounds of heparin].
    Kudriashov BA; Ul'ianov AM; Zhitnikova ES
    Dokl Akad Nauk SSSR; 1977; 237(4):965-8. PubMed ID: 590080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electron microscopic study of the products from dissolving unstabilized fibrin with complex heparin compounds].
    Ul'ianov AM; Zhitnikova ES
    Biokhimiia; 1978; 43(4):646-52. PubMed ID: 656495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electronmicroscopic study on the molecular shape of non-stabilized fibrin break-down products produced by complex heparin compounds].
    Kudrjashov BA; Uljanov AM; Shitnikova ES
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):895-905. PubMed ID: 6162756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electron microscopic study of the depolymerization process on unstabilized fibrin as affected by urea or monochloracetic acid].
    Ul'ianov AM; Zhitnikova ES
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (8):59-63. PubMed ID: 6226322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of nonenzymatic fibrinolysis].
    Litvinov VI; Slabnov IuD; Zubairov DM
    Vopr Med Khim; 1981; 27(4):478-81. PubMed ID: 6457444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
    McCulloch P; Douglas J; Lowe GD; Murray G; George WD
    Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of self-assembly of soluble fibrin oligomers and the role of fibrinopeptides A and B in this process].
    Rozenfel'd MA; Gershkovich KB; Kuznetsov DV; Meshkov BB; Gontar' ID
    Mol Biol (Mosk); 1986; 20(4):1098-110. PubMed ID: 3762532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor XIII-heparin complex and its properties as a physiological solvent for unstabilized fibrin].
    Ul'ianov AM; Kudriashov BA
    Vopr Med Khim; 1975; 21(1):19-23. PubMed ID: 235172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
    Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
    Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular markers of hemostatic mechanisms--fibrinopeptide B beta 1-42].
    Kuroso K
    Rinsho Byori; 1989 Mar; 37(3):234-9. PubMed ID: 2664279
    [No Abstract]   [Full Text] [Related]  

  • 17. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
    Flood VH; Nagaswami C; Chernysh IN; Al-Mondhiry HA; Weisel JW; Farrell DH
    Br J Haematol; 2007 Jul; 138(1):117-24. PubMed ID: 17555455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinogen and fibrinogenesis].
    Matthias FR
    Med Welt; 1975 Sep; 26(39):1786-9. PubMed ID: 1100992
    [No Abstract]   [Full Text] [Related]  

  • 19. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.